Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1998-03-11
1999-10-05
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31557
Patent
active
059625287
ABSTRACT:
Disclosed herein is method of treating and a composition for treating erectile dysfunction in a male patient by administering to the patient a unit dose of a formulation comprising an erectile dysfunction treating amount of a prostaglandin, namely prostaglandin E.sub.1, prostaglandin E.sub.2, or pharmaceutically acceptable salts or derivatives thereof, wherein the prostaglandin is formulated with a small amount of prostaglandin F.sub..alpha.2 together with a pharmaceutically acceptable delivery medium and/or a lubricant.
REFERENCES:
patent: 4311707 (1982-01-01), Birnbaum et al.
patent: 4801587 (1989-01-01), Voss et al.
patent: 4955878 (1990-09-01), See et al.
patent: 5242391 (1993-09-01), Place et al.
Schramek et al, Derwent Drug File Abstracts, vol. 90, abstract No. 01345, 1989.
"Impotence," Medical Aspects of Human Sexuality, pp. 66-68, May 1991.
Gauger, Laura J. and Curet, Louis B., "Comparative Efficacy of Intravaginal Prostaglandin E-2 in the Gel and Suppository Forms for Cervical Ripening,"DICP, The Annals of Pharmacotherapy,25:456-460, May 91.
Cavallini, Giorgio, "Minoxidil vs. Nitroglycerine: A Perspective Double Blind Controlled Trial in Transcutaneous Erection Facilitation for Organic Impotence,"The Journal of Urology, 146:50-53. Jul. 1991.
Artoux, Michelle J., "Alprostadil in Impotence, "DICP, The Annals of Pharmacotherapy, 25:363-365, Apr. 1991.
Burnakis, Thomas G., "Amyl Nitrite for the Treatment of Penile Tumescence," Hospital Pharmacy, 26:343-344, Apr. 1991.
Physicians' Desk Reference, 45th ed., pp. 627-628, 1991.
Lehninger, Albert L., Biochemistry, 2nd ed., 1975.
Ganong, William F., Review of Medical Physiology, 7th ed., pp. 187, 226, 1975.
Physicians' Desk Reference, 45th ed., pp. 2250-2251, 1991.
Catanzarite, Valerian A. and Aisenbrey, Gary, "Prostaglandins: Mundane and Visionary Applications," Contemporary Ob/Gyn, pp. 21-41, Oct. 1987.
"Agents for Patent Ductus Arteriosus," Facts & Comparisons, pp. 732-732a, Nov. 1989.
"Prostin E-2," package insert of the Upjohn Company, revised Oct. 1990.
"Hemabat," package insert of the Upjohn Company, reivsed Nov. 1989.
Andersen et a., "Molecular Basis for Prostaglandin Potency, III. Tests of the Significance of the "Hairpin Conformation" in Biorecognition Phenomena,Prostaglandins," vol. 22, No. 5, pp. 841-855, Nov. 1981.
Bernard et al., "The Roles of Urologist and Patient in Autoinjection Therapy for Erectile Dysfunction," Contemporary Urology, pp. 21-26, Jan./Feb. 1990.
Dray et al., "Prostaglandins of the E Series Inhibit Release of Noradrenaline in Rat Hypothalamus by a Mechanism Unrelated to Classical .alpha..sub.2, Adrenergic Presynaptic Inhibition," Neuropharmacology, vol. 23 No. 4, pp. 457-462, 1984.
Dunn, C.D.R., "Prostaglandins and Erythropoiesis: Structure/Action Relationships and Identification of the Prostaglandin Responsive Cells," Blut, 42, pp. 307-314, 1981.
Ganong, William F., "Chapter 17. Energy Balance, Metabolism and Nutrition," Review of Medical Physiology, pp. 229-231, 8th Edition, 1977.
Larock et al., "Organopalladium Approaches to Prostaglandins, Synthesis of PGF.sub.2.alpha. by the Controlled, One-Step, Palladium-Promoted, Intermolecular Coupling of Three Different Alkenes," J. Am. Chem. Soc., 113, 7815-7816, 1991.
Pasargiklian et al., Clinical, Functional and Pathogenetic Aspects of Bronchial Reactivity to Prostaglandins F.sub.2.alpha., E.sub.1, and E.sub.2, Advances in Prostaglandin and Thromboxane Research, vol. 1, pp. 461-475, 1976.
Takahashi et al., "Glomerular Actions of a Free Radical-Generated Novel Prostaglandin, 8-epi-Prostaglandin F.sub.2.alpha., in the Rat," J. Clin. Invest., vol. 90, 136-141, Jul. 1992.
Windholz, et al., "Prostaglandin(s)", The Merck Index, pp. 1134-1135, 1983.
Wolfson et al., "Intraurethral Prostaglandin E-2 Cram: A Possible Alternative Treatment for Erectile Dysfunction", Urology, vol. 42, No. 1, Jul. 1993 and Abstract of Article.
Zoutendam et al., "Quantitative Determination of Alprostadil (PGE.sub.1) in Bulk Drug and Pharmaceutical For ulations by High-Performance Liquid Chromatography," Journal of Chromatography, 283, 273-280, 1984.
Jarvis William R. A.
Ram Michael J.
LandOfFree
Prostaglandin E.sub.2 /F.sub.2.alpha. combination for treating does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin E.sub.2 /F.sub.2.alpha. combination for treating , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin E.sub.2 /F.sub.2.alpha. combination for treating will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1172196